Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus

17Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:. To assess the effects of pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of T2DM.

Cite

CITATION STYLE

APA

Ørskov Ipsen, E., Madsen, K. S., Pedersen-Bjergaard, U., Richter, B., Metzendorf, M. I., & Hemmingsen, B. (2020). Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus. Cochrane Database of Systematic Reviews, 2020(1). https://doi.org/10.1002/14651858.CD013516

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free